<VariationArchive VariationID="495549" VariationName="NM_000098.3(CPT2):c.98del (p.Gln33fs)" VariationType="Deletion" Accession="VCV000495549" Version="19" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2018-03-17" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="486906" VariationID="495549">
      <GeneList>
        <Gene Symbol="CPT2" FullName="carnitine palmitoyltransferase 2" GeneID="1376" HGNC_ID="HGNC:2330" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1p32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="53196824" stop="53214197" display_start="53196824" display_stop="53214197" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="53662100" stop="53679868" display_start="53662100" display_stop="53679868" Strand="+" />
          </Location>
          <OMIM>600650</OMIM>
        </Gene>
        <Gene Symbol="LOC129930561" FullName="ATAC-STARR-seq lymphoblastoid silent region 902" GeneID="129930561" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1p32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="53196808" stop="53197167" display_start="53196808" display_stop="53197167" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000098.3(CPT2):c.98del (p.Gln33fs)</Name>
      <CanonicalSPDI>NC_000001.11:53197040:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="53197041" stop="53197041" display_start="53197041" display_stop="53197041" variantLength="1" positionVCF="53197040" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="53662713" stop="53662713" display_start="53662713" display_stop="53662713" variantLength="1" positionVCF="53662712" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>p.Gln33Argfs*40</Name>
      </OtherNameList>
      <ProteinChange>Q33fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.53662713del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.53662713del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.53197041del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.53197041del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008035.1" sequenceAccession="NG_008035" sequenceVersion="1" change="g.5613del">
            <Expression>NG_008035.1:g.5613del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000098.3" sequenceAccession="NM_000098" sequenceVersion="3" change="c.98del" MANESelect="true">
            <Expression>NM_000098.3:c.98del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000089.1" sequenceAccession="NP_000089" sequenceVersion="1" change="p.Gln33fs">
            <Expression>NP_000089.1:p.Gln33fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330589.2" sequenceAccession="NM_001330589" sequenceVersion="2" change="c.98del">
            <Expression>NM_001330589.2:c.98del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317518.1" sequenceAccession="NP_001317518" sequenceVersion="1" change="p.Gln33fs">
            <Expression>NP_001317518.1:p.Gln33fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000098.3" sequenceAccession="NM_000098" sequenceVersion="3" change="c.98delA" MANESelect="true">
            <Expression>NM_000098.3:c.98delA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000098.2" sequenceAccession="NM_000098" sequenceVersion="2" change="c.98del">
            <Expression>NM_000098.2:c.98del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA22626436" DB="ClinGen" />
        <XRef Type="rs" ID="917744011" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00005" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000098.3(CPT2):c.98del (p.Gln33fs) AND Carnitine palmitoyl transferase II deficiency, severe infantile form" Accession="RCV000984252" Version="2">
        <ClassifiedConditionList TraitSetID="2467">
          <ClassifiedCondition DB="MedGen" ID="C1833511">Carnitine palmitoyl transferase II deficiency, severe infantile form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-11" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000098.3(CPT2):c.98del (p.Gln33fs) AND Carnitine palmitoyltransferase II deficiency" Accession="RCV000588722" Version="7">
        <ClassifiedConditionList TraitSetID="10067">
          <ClassifiedCondition DB="MedGen" ID="C0342790">Carnitine palmitoyltransferase II deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-29" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000098.3(CPT2):c.98del (p.Gln33fs) AND not provided" Accession="RCV001569307" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-07-11" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000098.3(CPT2):c.98del (p.Gln33fs) AND multiple conditions" Accession="RCV002483563" Version="1">
        <ClassifiedConditionList TraitSetID="10518">
          <ClassifiedCondition DB="MedGen" ID="C1833508">Carnitine palmitoyl transferase II deficiency, myopathic form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833518">Carnitine palmitoyl transferase II deficiency, neonatal form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833511">Carnitine palmitoyl transferase II deficiency, severe infantile form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3280160">Encephalopathy, acute, infection-induced, susceptibility to, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000098.3(CPT2):c.98del (p.Gln33fs) AND Encephalopathy, acute, infection-induced, susceptibility to, 4" Accession="RCV003471935" Version="2">
        <ClassifiedConditionList TraitSetID="7602">
          <ClassifiedCondition DB="MedGen" ID="C3280160">Encephalopathy, acute, infection-induced, susceptibility to, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000098.3(CPT2):c.98del (p.Gln33fs) AND multiple conditions" Accession="RCV004554810" Version="1">
        <ClassifiedConditionList TraitSetID="20886">
          <ClassifiedCondition DB="MedGen" ID="C1833518">Carnitine palmitoyl transferase II deficiency, neonatal form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833511">Carnitine palmitoyl transferase II deficiency, severe infantile form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-25" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2018-03-17" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16781677</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16996287</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21913903</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30957255</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20886" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, lethal neonatal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, neonatal form</ElementValue>
                <XRef ID="MONDO:0012136" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, LETHAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, LETHAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17151" />
                <XRef ID="17151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="228308" DB="Orphanet" />
              <XRef ID="C1833518" DB="MedGen" />
              <XRef ID="MONDO:0012136" DB="MONDO" />
              <XRef Type="MIM" ID="608836" DB="OMIM" />
            </Trait>
            <Trait ID="686" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, severe infantile form</ElementValue>
                <XRef ID="MONDO:0010914" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II deficiency, infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, infantile</ElementValue>
                <XRef ID="Carnitine+palmitoyltransferase+II+deficiency%2C+infantile/7904" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, HEPATIC</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY WITH HYPOKETOTIC HYPOGLYCEMIA</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, HEPATOCARDIOMUSCULAR</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, INFANTILE</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17150" />
                <XRef ID="17150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="228305" DB="Orphanet" />
              <XRef ID="C1833511" DB="MedGen" />
              <XRef ID="MONDO:0010914" DB="MONDO" />
              <XRef Type="MIM" ID="600649" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2467" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="686" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, severe infantile form</ElementValue>
                <XRef ID="MONDO:0010914" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II deficiency, infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, infantile</ElementValue>
                <XRef ID="Carnitine+palmitoyltransferase+II+deficiency%2C+infantile/7904" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, HEPATIC</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY WITH HYPOKETOTIC HYPOGLYCEMIA</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, HEPATOCARDIOMUSCULAR</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, INFANTILE</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17150" />
                <XRef ID="17150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="228305" DB="Orphanet" />
              <XRef ID="C1833511" DB="MedGen" />
              <XRef ID="MONDO:0010914" DB="MONDO" />
              <XRef Type="MIM" ID="600649" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7602" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16567" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Encephalopathy, acute, infection-induced, susceptibility to, 4</ElementValue>
                <XRef ID="MONDO:0013633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IIAE4</ElementValue>
                <XRef Type="MIM" ID="614212" DB="OMIM" />
              </Symbol>
              <XRef ID="263524" DB="Orphanet" />
              <XRef ID="C3280160" DB="MedGen" />
              <XRef ID="MONDO:0013633" DB="MONDO" />
              <XRef Type="MIM" ID="614212" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10518" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, lethal neonatal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, neonatal form</ElementValue>
                <XRef ID="MONDO:0012136" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, LETHAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, LETHAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17151" />
                <XRef ID="17151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="228308" DB="Orphanet" />
              <XRef ID="C1833518" DB="MedGen" />
              <XRef ID="MONDO:0012136" DB="MONDO" />
              <XRef Type="MIM" ID="608836" DB="OMIM" />
            </Trait>
            <Trait ID="16567" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Encephalopathy, acute, infection-induced, susceptibility to, 4</ElementValue>
                <XRef ID="MONDO:0013633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IIAE4</ElementValue>
                <XRef Type="MIM" ID="614212" DB="OMIM" />
              </Symbol>
              <XRef ID="263524" DB="Orphanet" />
              <XRef ID="C3280160" DB="MedGen" />
              <XRef ID="MONDO:0013633" DB="MONDO" />
              <XRef Type="MIM" ID="614212" DB="OMIM" />
            </Trait>
            <Trait ID="686" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, severe infantile form</ElementValue>
                <XRef ID="MONDO:0010914" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II deficiency, infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, infantile</ElementValue>
                <XRef ID="Carnitine+palmitoyltransferase+II+deficiency%2C+infantile/7904" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, HEPATIC</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY WITH HYPOKETOTIC HYPOGLYCEMIA</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, HEPATOCARDIOMUSCULAR</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, INFANTILE</ElementValue>
                <XRef Type="MIM" ID="600649" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17150" />
                <XRef ID="17150" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="228305" DB="Orphanet" />
              <XRef ID="C1833511" DB="MedGen" />
              <XRef ID="MONDO:0010914" DB="MONDO" />
              <XRef Type="MIM" ID="600649" DB="OMIM" />
            </Trait>
            <Trait ID="727" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, late-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, myopathic form</ElementValue>
                <XRef ID="MONDO:0009704" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II deficiency, myopathic, stress-induced</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, MYOPATHIC</ElementValue>
                <XRef Type="MIM" ID="255110" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ADULT-ONSET</ElementValue>
                <XRef Type="MIM" ID="255110" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC</ElementValue>
                <XRef Type="MIM" ID="255110" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, LATE-ONSET</ElementValue>
                <XRef Type="MIM" ID="255110" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17149" />
                <XRef ID="17149" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="157" DB="Orphanet" />
              <XRef ID="228302" DB="Orphanet" />
              <XRef ID="C1833508" DB="MedGen" />
              <XRef ID="MONDO:0009704" DB="MONDO" />
              <XRef Type="MIM" ID="255110" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10067" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6221" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyl transferase 2 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyltransferase II deficiency</ElementValue>
                <XRef ID="MONDO:0015515" DB="MONDO" />
                <XRef ID="238002005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase deficiency type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CPT2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1121" />
                <XRef ID="1121" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Carnitine-Palmitoyltransferase-2-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased C16 and/or C18:1 Acylcarnitine, Carnitine Palmitoyltransferase II (CPT II) Deficiency and Carnitine Acylcarnitine Translocase (CACT) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-C18-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, C16 +/- C18:1 Elevated: CPT II or CACT, 2022</CitationText>
              </Citation>
              <XRef ID="157" DB="Orphanet" />
              <XRef ID="C0342790" DB="MedGen" />
              <XRef ID="MONDO:0015515" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1361759" SubmissionDate="2018-01-25" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_000098.2:c.98delA|MedGen:C0342790" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000695407" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21913903</ID>
          </Citation>
          <Comment>Variant summary: The c.98delA (p.Gln33Argfs) variant in CPT2 gene is a frameshift change that results in the loss of the 589 amino acids of CPT (~90%). This change is predicted to cause loss of normal protein function through protein truncation or nonsense-mediated mRNA decay. The variant is absent from the large control population dataset of ExAC, but has been reported in at least 1 severely affected individual in compound heterozygosity with a known pathogenic variant (p.S113L) via published report. Taking together, the variant was classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.2:c.98delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342790" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2235460" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2019-12-23">
        <ClinVarSubmissionID localKey="42871|OMIM:600649" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001132375" DateUpdated="2019-12-23" DateCreated="2019-12-23" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-07-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21913903</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="C" referenceAllele="CA" start="53662712" stop="53662713" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600649" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2876485" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000098.3:c.98delA|Carnitine palmitoyltransferase II deficiency" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001461210" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.98delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Carnitine palmitoyltransferase II deficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5427815" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000098.3:c.98del|OMIM:255110;600649;608836;614212" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002778553" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.98del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="255110" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600649" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608836" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614212" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3522130" SubmissionDate="2022-04-27" DateLastUpdated="2023-03-04" DateCreated="2021-08-21">
        <ClinVarSubmissionID localKey="GDXSV:225499" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001793355" DateUpdated="2023-03-04" DateCreated="2021-08-21" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at a significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 30957255, 21913903)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:717435</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.2:c.98del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_103_20220427054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_25_20210818160340</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7820883" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_000098.3:c.98del|OMIM:600649" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004179248" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.98del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600649" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095410</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7895043" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1621751|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004225836" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21913903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30957255</ID>
          </Citation>
          <Comment>PP4, PM2, PM3, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000098.3:exon 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Gln33Argfs*40</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.98del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2385238" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4815732|MedGen:C0342790" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001219804" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21913903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16781677</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16996287</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 495549). This premature translational stop signal has been observed in individual(s) with clinical features of CPT2 deficiency (PMID: 21913903). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Gln33Argfs*40) in the CPT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPT2 are known to be pathogenic (PMID: 16781677, 16996287).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.53662713del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342790" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9791096" SubmissionDate="2024-05-15" DateLastUpdated="2024-05-19" DateCreated="2024-05-19">
        <ClinVarSubmissionID localKey="NM_000098.3:c.98del" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005044147" DateUpdated="2024-05-19" DateCreated="2024-05-19" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21913903</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30957255</ID>
          </Citation>
          <Comment>The inherited variant c.98del in CPT2 has previously been reported in individuals with Carnitine Palmitoyltransferase II Deficiency [PMID: 21913903, 30957255] and has been deposited in ClinVar [ClinVar ID: 495549] as Pathogenic/Likely Pathogenic. The c.98del variant is observed in 27 alleles with 0 homozygotes in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases. The c.98del variant in CPT2 is located in exon 1 of this 5-exon gene, predicted to incorporate a premature termination codon (p.(Gln33ArgfsTer40)), and is expected to result in loss-of-function via nonsense mediated decay. Multiple loss-of-function variants that are downstream to the c.98del variant have been reported in the literature [PMID: 20301431] in individuals with Carnitine Palmitoyltransferase II Deficiency. Based on available evidence, this inherited c.98del p.(Gln33ArgfsTer40) variant identified in CPT2 is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/hhfhf6ms/nygc_assertion_criteria_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="weeks gestation">20</Age>
              <Age Type="maximum" age_unit="weeks gestation">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000105" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.98del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600649" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608836" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>PrenatalSEQ</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB14405054</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7866985" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000098.3:c.98del|OMIM:614212" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004211039" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000098.3:c.98del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614212" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7866985" TraitType="Disease" MappingType="XRef" MappingValue="614212" MappingRef="OMIM">
        <MedGen CUI="C3280160" Name="Encephalopathy, acute, infection-induced, susceptibility to, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1361759" TraitType="Disease" MappingType="XRef" MappingValue="C0342790" MappingRef="MedGen">
        <MedGen CUI="C0342790" Name="Carnitine palmitoyltransferase II deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3522130" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9791096" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000105" MappingRef="HP">
        <MedGen CUI="C0542518" Name="Enlarged kidney" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427815" TraitType="Disease" MappingType="XRef" MappingValue="255110" MappingRef="OMIM">
        <MedGen CUI="C1833508" Name="Carnitine palmitoyl transferase II deficiency, myopathic form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427815" TraitType="Disease" MappingType="XRef" MappingValue="614212" MappingRef="OMIM">
        <MedGen CUI="C3280160" Name="Encephalopathy, acute, infection-induced, susceptibility to, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7820883" TraitType="Disease" MappingType="XRef" MappingValue="600649" MappingRef="OMIM">
        <MedGen CUI="C1833511" Name="Carnitine palmitoyl transferase II deficiency, severe infantile form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9791096" TraitType="Disease" MappingType="XRef" MappingValue="600649" MappingRef="OMIM">
        <MedGen CUI="C1833511" Name="Carnitine palmitoyl transferase II deficiency, severe infantile form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2876485" TraitType="Disease" MappingType="Name" MappingValue="Carnitine palmitoyltransferase II deficiency" MappingRef="Preferred">
        <MedGen CUI="C0342790" Name="Carnitine palmitoyltransferase II deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7895043" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9791096" TraitType="Disease" MappingType="XRef" MappingValue="608836" MappingRef="OMIM">
        <MedGen CUI="C1833518" Name="Carnitine palmitoyl transferase II deficiency, neonatal form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427815" TraitType="Disease" MappingType="XRef" MappingValue="608836" MappingRef="OMIM">
        <MedGen CUI="C1833518" Name="Carnitine palmitoyl transferase II deficiency, neonatal form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2385238" TraitType="Disease" MappingType="XRef" MappingValue="C0342790" MappingRef="MedGen">
        <MedGen CUI="C0342790" Name="Carnitine palmitoyltransferase II deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2235460" TraitType="Disease" MappingType="XRef" MappingValue="600649" MappingRef="OMIM">
        <MedGen CUI="C1833511" Name="Carnitine palmitoyl transferase II deficiency, severe infantile form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427815" TraitType="Disease" MappingType="XRef" MappingValue="600649" MappingRef="OMIM">
        <MedGen CUI="C1833511" Name="Carnitine palmitoyl transferase II deficiency, severe infantile form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

